PGR and breast cancer: demonstrated that the AKT1-E17K mutation is restricted to breast cancers expressing both ER and PR, and confirmed that AKT1-E17K, PIK3CA, and PTEN mutations are mutually exclusive in breast cancer cell lines, similarly to other tumor types (72).